Making Safer Nanomedicine
![]() |
Some nanomaterials can ferry cancer drugs to tumors; others can act as bright contrast agents for infrared or magnetic-resonance imaging.
While researchers are working to make these materials even more efficient tumor targeters and imaging agents, they will also need to make sure they are safe. But until now, “there has been little effort to engineer the self-destruction [of nanomaterials]…into non-toxic, systemically-eliminated products,” write researchers in this week’s issue of Nature Materials.
The nanoparticles haven’t been tested in clinical trials yet, but there is good reason to suspect they’ll be harmless in people. For one thing, earlier this month researchers presented results at the American Association for the Advancement of Science meeting of a gene expression study demonstrating that exposing human immune cells to silica particles with a range of different surface areas didn’t harm the cells. And the researchers felt comfortable enough to expose themselves for the above photo, which shows the nanoparticles emitting fluorescent light under UV.
Keep Reading
Most Popular

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.